Reference
1. Houben RM, Dodd PJ. The Global Burden of Latent Tuberculosis
Infection: A Re-estimation Using Mathematical Modelling. PLoS medicine
2016; 13: e1002152.
2. Lee MR, Ho CM, Lee CH, Lee MC, Chang LY, Yu KL, Ko JC, Wang JY, Wang
JT, Lee LN. Tuberculosis contact investigation in an intermediate burden
setting: implications from a large tuberculosis contact cohort in
Taiwan. The European respiratory journal 2017; 50.
3. Lee C-H, Wang J-Y, Lin H-C, Lin P-Y, Chang J-H, Suk C-W, Lee L-N, Lan
C-C, Bai K-J. Treatment delay and fatal outcomes of pulmonary
tuberculosis in advanced age: a retrospective nationwide cohort study.
BMC infectious diseases 2017; 17: 449.
4. Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D.
Incidence of serious side effects from first-line antituberculosis drugs
among patients treated for active tuberculosis. American journal of
respiratory and critical care medicine 2003; 167: 1472-7.
5. Forget EJ, Menzies D. Adverse reactions to first-line
antituberculosis drugs. Expert opinion on drug safety 2006; 5: 231-49.
6. Lin Y-Y, Huang C-S. Aging in Taiwan: Building a Society for Active
Aging and Aging in Place. The Gerontologist 2015; 56: 176-83.
7. Awofeso N. Anti-tuberculosis medication side-effects constitute major
factor for poor adherence to tuberculosis treatment. Bulletin of the
World Health Organization 2008; 86: B-d.
8. De Vriese AS, Robbrecht DL, Vanholder RC, Vogelaers DP, Lameire NH.
Rifampicin-associated acute renal failure: pathophysiologic,
immunologic, and clinical features. American journal of kidney diseases
: the official journal of the National Kidney Foundation 1998; 31:
108-15.
9. Kumar S, Mehta JA, Trivedi HL. Light-chain proteinuria and reversible
renal failure in rifampin-treated patients with tuberculosis. Chest
1976; 70: 564-5.
10. Winter RJ, Banks RA, Collins CM, Hoffbrand BI. Rifampicin induced
light chain proteinuria and renal failure. Thorax 1984; 39: 952-3.
11. Kwon SH, Kim JH, Yang JO, Lee EY, Hong SY. Ethambutol-induced acute
renal failure. Nephrology, dialysis, transplantation : official
publication of the European Dialysis and Transplant Association -
European Renal Association 2004; 19: 1335-6.
12. Trainin EB, Turin RD, Gomez-Leon G. Acute renal insufficiency
complicating isoniazid therapy. The International journal of pediatric
nephrology 1981; 2: 53-4.
13. Covic A, Goldsmith DJ, Segall L, Stoicescu C, Lungu S, Volovat C,
Covic M. Rifampicin-induced acute renal failure: a series of 60
patients. Nephrology, dialysis, transplantation : official publication
of the European Dialysis and Transplant Association - European Renal
Association 1998; 13: 924-9.
14. Chang CH, Chen YF, Wu VC, Shu CC, Lee CH, Wang JY, Lee LN, Yu CJ.
Acute kidney injury due to anti-tuberculosis drugs: a five-year
experience in an aging population. BMC infectious diseases 2014; 14: 23.
15. Schubert C, Bates WD, Moosa MR. Acute tubulointerstitial nephritis
related to antituberculous drug therapy. Clinical nephrology 2010; 73:
413-9.
16. Muthukumar T, Jayakumar M, Fernando EM, Muthusethupathi MA. Acute
renal failure due to rifampicin: a study of 25 patients. American
journal of kidney diseases : the official journal of the National Kidney
Foundation 2002; 40: 690-6.
17. Centers for Disease Control MoHaW, R.O.C.(Taiwan). Taiwan Guidelines
for TB Diagnosis & Treatment (6E). 2017.
18. Khwaja A. KDIGO clinical practice guidelines for acute kidney
injury. Nephron Clinical practice 2012; 120: c179-84.
19. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S,
Kusek JW, Van Lente F. Using standardized serum creatinine values in the
modification of diet in renal disease study equation for estimating
glomerular filtration rate. Annals of internal medicine 2006; 145:
247-54.
20. O’Sullivan ED, Hughes J, Ferenbach DA. Renal Aging: Causes and
Consequences. Journal of the American Society of Nephrology 2017; 28:
407-20.
21. Coca SG. Acute kidney injury in elderly persons. American journal of
kidney diseases : the official journal of the National Kidney Foundation
2010; 56: 122-31.
22. Finlay S, Bray B, Lewington AJ, Hunter-Rowe CT, Banerjee A, Atkinson
JM, Jones MC. Identification of risk factors associated with acute
kidney injury in patients admitted to acute medical units. Clinical
medicine (London, England) 2013; 13: 233-8.
23. Cheng Y, Luo R, Wang X, Wang K, Zhang N, Zhang M, Wang Z, Dong L, Li
J, Zeng R, Yao Y, Ge S, Xu G. The Incidence, Risk Factors, and Prognosis
of Acute Kidney Injury in Adult Patients with Coronavirus Disease 2019.
Clinical Journal of the American Society of Nephrology 2020; 15:
1394-402.
24. Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders
H-J. Acute kidney injury. Nature Reviews Disease Primers 2021; 7: 52.
25. Waikar SS, Bonventre JV. Creatinine kinetics and the definition of
acute kidney injury. Journal of the American Society of Nephrology :
JASN 2009; 20: 672-9.
26. Perazella MA, Rosner MH. Drug-Induced Acute Kidney Injury. Clinical
Journal of the American Society of Nephrology 2022: CJN.11290821.
27. Muriithi AK, Nasr SH, Leung N. Utility of Urine Eosinophils in the
Diagnosis of Acute Interstitial Nephritis. Clinical Journal of the
American Society of Nephrology 2013; 8: 1857-62.
28. Perazella MA. AKI in a hospitalized patient with cellulitis.
Clinical journal of the American Society of Nephrology : CJASN 2013; 8:
658-64.
29. Perazella MA, Markowitz GS. Drug-induced acute interstitial
nephritis. Nature reviews Nephrology 2010; 6: 461-70.
30. Matz J, Borish LC, Routes JM, Rosenwasser LJ. Oral desensitization
to rifampin and ethambutol in mycobacterial disease. American journal of
respiratory and critical care medicine 1994; 149: 815-7.
31. Kim JH, Kim HB, Kim BS, Hong SJ. Rapid oral desensitization to
isoniazid, rifampin, and ethambutol. Allergy 2003; 58: 540-1.
Table 1. Patient characteristics, stratified by status of acute
kidney injury (AKI)